Search results for "Cardiovascular agents"

showing 10 items of 62 documents

Antiplatelet effects of intravenous iloprost in patients with peripheral arterial obliterative disease

1986

The dose-dependent inhibition of platelet aggregation by the chemically stable, prostacyclin-mimetic, iloprost, was studied in patients suffering from stage II-III peripheral arterial obliterative disease (PAOD). The study was designed as a randomized placebo-controlled cross-over trial. Iloprost was administered i.v. to six patients at doses of 0.5, 1.0, 2.0 or 3.0 ng/kg X min for 4 h, with an interval of 2-3 days between the infusions. During iloprost infusion, systolic and diastolic arterial blood pressure, heart rate and blood flow in the affected limb remained unchanged. In contrast, there was a considerable, dose-dependent inhibition of ADP- and thrombin-induced platelet aggregation a…

AdultMaleTime FactorsPlatelet AggregationDiastoleHemodynamicsArterial Occlusive DiseasesPlaceboRandom AllocationDrug DiscoveryHeart ratemedicineHumansPlateletIloprostGenetics (clinical)AgedDose-Response Relationship Drugbusiness.industryHemodynamicsCardiovascular AgentsGeneral MedicineMiddle AgedEpoprostenolBlood pressureAnesthesiaCardiovascular agentDrug EvaluationMolecular MedicineFemalelipids (amino acids peptides and proteins)businesscirculatory and respiratory physiologyIloprostmedicine.drugKlinische Wochenschrift
researchProduct

Regular use of aspirin for cardiovascular disease prevention in Italy

2013

Abstract Objective Only a few European studies focused on aspirin use in the general population. We provide updated information on the prevalence and determinants of regular aspirin use for the prevention of cardiovascular disease (CVD) in the Italian adult population. Method We used data from a survey conducted in Italy in 2013, on a sample of 3000 individuals, representative of the general Italian population aged ≥ 15 years. Results Overall, 10.9% of Italians reported a regular use of aspirin, 11.2% of men and 10.5% of women. Aspirin use significantly increased with age. The highest prevalence of aspirin use was observed among the elderly (30.3%), ex-smokers (22.6%), and in individuals wi…

AdultMalemedicine.medical_specialtyAdolescentEpidemiologyPopulationAdult populationDiseaseYoung AdultInternal medicineDiabetes mellitusPrevalencemedicineHumanseducationAgedAged 80 and overeducation.field_of_studyAspirinPreventive strategyAspirinbusiness.industryPublic Health Environmental and Occupational HealthCardiovascular AgentsMiddle Agedmedicine.diseaseItalyCardiovascular DiseasesPhysical therapyFemaleDisease preventionbusinessBody mass indexmedicine.drugPreventive Medicine
researchProduct

Combination of indomethacin and statin compared with indomethacin and placebo in patients with a first episode of acute pericarditis: preliminary fin…

2007

The aim of the present study was to evaluate the safety and efficacy of the combination of indomethacin and statin compared with indomethacin plus placebo in patients with a first episode of pericarditis. A total of 55 consecutive patients with acute pericarditis were randomized in a double-blind manner into two groups: group I (statin group) was treated with 150 mg of indomethacin plus 10 mg of rosuvastatin, and group 2 (placebo group) was treated with 150 mg of indomethacin plus placebo. Both groups received treatment up to the normalization of inflammation markers and for the following week. Clinical and laboratory assessments [white cell count, ESR (erythrocyte sedimentation rate) and C…

AdultMalemedicine.medical_specialtyIndomethacinPlaceboGastroenterologyElectrocardiographyPericarditisAcute pericarditisDouble-Blind MethodRecurrenceInternal medicineTroponin ImedicineHumansPericarditisRosuvastatinRosuvastatin CalciumPericarditis Colchicine Postpericardiotomy syndromeFirst episodeSulfonamidesmedicine.diagnostic_testbiologybusiness.industryAnti-Inflammatory Agents Non-SteroidalCardiovascular AgentsGeneral Medicinemedicine.diseaseSurgeryFluorobenzenesC-Reactive ProteinPyrimidinesTreatment OutcomeErythrocyte sedimentation rateAcute Diseasebiology.proteinDrug Therapy CombinationFemaleCreatine kinaseHydroxymethylglutaryl-CoA Reductase InhibitorsInflammation MediatorsbusinessFollow-Up Studiesmedicine.drugClinical Science
researchProduct

Prognostic effect of carbohydrate antigen 125-guided therapy in patients recently discharged for acute heart failure (CHANCE-HF). Study design.

2014

Abstract Introduction and objectives Morbidity and mortality after admission for acute heart failure remain prohibitively high. In that setting, plasma levels of antigen carbohydrate 125 have shown to correlate with the severity of fluid overload and the risk of mortality and readmission. Preliminary data suggests a potential role of antigen carbohydrate 125 to guide therapy. The objective of this study is to evaluate the prognostic effect of an antigen carbohydrate 125-guided management strategy vs standard therapy in patients recently discharged for acute heart failure. Methods This is a multicenter, randomized, single-blind, efficacy trial study of patients recently discharged from acute…

AdultMalemedicine.medical_specialtyRandomizationTime FactorsRisk AssessmentAntigenCause of DeathRisk of mortalityMedicineHumansIn patientSingle-Blind MethodProspective StudiesIntensive care medicineAgedHeart Failurebusiness.industryStandard treatmentDisease ManagementCardiovascular AgentsGeneral MedicineMiddle Agedmedicine.diseasePrognosisPatient DischargeClinical trialSurvival RateSpainHeart failureCA-125 AntigenAcute DiseaseFemalebusinessCarbohydrate antigenBiomarkersFollow-Up StudiesRevista espanola de cardiologia (English ed.)
researchProduct

Nemaline myopathy and heart failure: role of ivabradine; a case report

2015

Background Nemaline myopathy (NM) is a rare congenital myopathy characterized by muscle weakness, hypotonia and the presence in muscle fibers of inclusions known as nemaline bodies and a wide spectrum of clinical phenotypes, ranging from severe forms with neonatal onset to asymptomatic forms. The adult-onset form is heterogeneous in terms of clinical presentation and disease progression. Cardiac involvement occurs in the minority of cases and little is known about medical management in this subgroup of NM patients. We report a rare case of heart failure (HF) in a patient with adult-onset NM in whom ivabradine proved to be able to dramatically improve the clinical picture. Case presentation …

AdultMalemedicine.medical_specialtymedicine.medical_treatmentDilated cardiomyopathyCase ReportMyopathies NemalineElectrocardiographyNemaline myopathyInternal medicinemedicineHumansIvabradineCarvedilolNemaline myopathyHeart FailureEjection fractionbusiness.industryDilated cardiomyopathyCardiovascular AgentsBenzazepinesmedicine.diseaseImplantable cardioverter-defibrillatorCongenital myopathyTreatment OutcomeEchocardiographyHeart failureCardiologybusinessCardiology and Cardiovascular MedicineIvabradinemedicine.drugBMC Cardiovascular Disorders
researchProduct

Phase information of time-frequency transforms as a key feature for classification of atrial fibrillation episodes

2015

[EN] Patients suffering from atrial fibrillation can be classified into different subtypes, according to the temporal pattern of the arrhythmia and its recurrence. Nowadays, clinicians cannot differentiate a priori between the different subtypes, and patient classification is done afterwards, when its clinical course is available. In this paper we present a comparison of classification performances when differentiating paroxysmal and persistent atrial fibrillation episodes by means of support vector machines. We analyze short surface electrocardiogram recordings by extracting modulus and phase features from several time-frequency transforms: short-time Fourier transform, Wigner-Ville, Choi-…

AdultSupport Vector MachineEXPRESION GRAFICA EN LA INGENIERIAPhysiologyBiomedical EngineeringBiophysicsPhase (waves)Sensitivity and SpecificityS-transform general Fourier-family transformCohort StudiesTertiary Care CentersElectrocardiographysymbols.namesakeText miningPhysiology (medical)Atrial FibrillationmedicineHumanscardiovascular diseasesAgedAged 80 and overPrincipal Component AnalysisFourier Analysisbusiness.industryCardiovascular AgentsAtrial fibrillationPattern recognitionMiddle Agedmedicine.diseaseAtrial fibrillationTime–frequency analysisSupport vector machineFourier transformROC CurveFeature (computer vision)Fourier analysisArea Under CurveTime-frequency transformsHypertensionsymbolsArtificial intelligenceMedical emergencybusiness
researchProduct

Effect of divalent cations on KCl- and noradrenaline-induced contractile responses in rat aorta after nifedipine treatment.

1999

Abstract Nifedipine (1 μM) relaxed the sustained contractile responses induced by 1 μM noradrenaline or 60 mM KCl in rat aortic strips. After washing, a second addition of the spasmogens gave smaller tonic contractions than the first one. Even more, a third addition of KCl also gave a smaller contraction than the first one, but a complete recovery of the contractile response to noradrenaline was obtained by a third addition of this agonist. Application of cumulative amounts of Ca2+ or Ba2+ (2.4–24 mM) on the residual contraction in response to these agents after nifedipine treatment, but in the absence of the blocker, restored the magnitude of the contractile responses. Addition of cumulati…

AgonistMalemedicine.medical_specialtyContraction (grammar)Nifedipinemedicine.drug_classCations DivalentVasodilator AgentsAorta ThoracicIn Vitro TechniquesTonic (physiology)DivalentPotassium ChlorideNorepinephrineNifedipineInternal medicinemedicine.arterymedicineAnimalsVasoconstrictor AgentsRats WistarPharmacologychemistry.chemical_classificationAortaChemistryCardiovascular AgentsRatsEndocrinologyVasoconstrictionCalciummedicine.symptomIsotonic SolutionsVasoconstrictionMuscle contractionmedicine.drugGeneral pharmacology
researchProduct

A rare case of Prinzmetal angina 3 days after coronary artery stenting with a second-generation drug-eluting stent

2015

Non previsto.

Angina Pectoris VariantMaleCoronary angiographymedicine.medical_specialtyTime FactorsVasodilator Agentsmedicine.medical_treatmentCoronary VasospasmPrinzmetal angina coronary artery stenting stent second-generation drug-eluting stent.Coronary AngiographyProsthesis DesignBalloonAnginaAngioplastyInternal medicineRare caseHumansMedicineEverolimusAngioplasty Balloon CoronarySirolimusEverolimusbusiness.industryCoronary StenosisCardiovascular AgentsDrug-Eluting StentsGeneral MedicineMiddle Agedmedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareTreatment Outcomemedicine.anatomical_structureDrug-eluting stentCardiologyPrinzmetal angina coronary artery stentingdrug-eluting stentCardiology and Cardiovascular Medicinebusinessmedicine.drugArteryCoronary Artery Disease
researchProduct

Pterostilbene: Biomedical applications

2013

Resveratrol and its naturally dimethylated analog, pterostilbene, show similar biological activities. However, the higher in vivo bioavailability of pterostilbene represents a fundamental advantage. The main focus of this review is on biomedical applications of pterostilbene. The metabolism and pharmacokinetics of this stilbene in inflammatory dermatoses and photoprotection, cancer prevention and therapy, insulin sensitivity, blood glycemia and lipid levels, cardiovascular diseases, aging, and memory and cognition are addressed. Safety and toxicity, as well as recommendations for future research and biomedical uses, are discussed. This review includes comparisons between pterostilbene and o…

Biomedical ResearchCancer preventionPterostilbenePlant Extractsbusiness.industryBiochemistry (medical)Clinical BiochemistryInsulin sensitivityAntineoplastic AgentsCardiovascular AgentsResveratrolPharmacologyProtective AgentsGeneral Biochemistry Genetics and Molecular BiologyCell Linechemistry.chemical_compoundchemistryStilbenesAnimalsHumansMedicinebusinessCritical Reviews in Clinical Laboratory Sciences
researchProduct

Cardiovascular effects and molecular targets of resveratrol

2012

Resveratrol (3,5,4'-trihydroxy-trans-stilbene) is a polyphenol phytoalexin present in a variety of plant species and has been implicated to explain the health benefits of red wine. A wide range of health beneficial effects have been demonstrated for resveratrol in animal studies. In this review, we summarize the cardiovascular effects of resveratrol with emphasis on the molecular targets of the compound. In this regard, resveratrol stimulates endothelial production of nitric oxide, reduces oxidative stress, inhibits vascular inflammation and prevents platelet aggregation. In animal models of cardiovascular disease, resveratrol protects the heart from ischemia-reperfusion injury, reduces blo…

Cancer Researchmedicine.medical_specialtyPhysiologyClinical BiochemistryEstrogen receptorResveratrolPharmacologyNitric Oxidemedicine.disease_causeBiochemistryNitric oxidechemistry.chemical_compoundInternal medicineStilbenesmedicineAnimalsHumansMolecular Targeted TherapyProtein kinase AbiologySirtuin 1food and beveragesCardiovascular AgentsEndocrinologychemistryCardiovascular DiseasesResveratrolbiology.proteinProtein deacetylaseAnimal studiesOxidative stressNitric Oxide
researchProduct